Pelthos Therapeutics Stock Alpha and Beta Analysis
| PTHS Stock | 26.50 0.48 1.78% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pelthos Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pelthos Therapeutics over a specified time horizon. Remember, high Pelthos Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pelthos Therapeutics' market risk premium analysis include:
Beta 1.57 | Alpha (0.27) | Risk 5.53 | Sharpe Ratio (0.03) | Expected Return (0.18) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Pelthos Therapeutics Backtesting, Pelthos Therapeutics Valuation, Pelthos Therapeutics Correlation, Pelthos Therapeutics Hype Analysis, Pelthos Therapeutics Volatility, Pelthos Therapeutics History and analyze Pelthos Therapeutics Performance. Pelthos Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pelthos Therapeutics market risk premium is the additional return an investor will receive from holding Pelthos Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pelthos Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pelthos Therapeutics' performance over market.| α | -0.27 | β | 1.57 |
Pelthos Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pelthos Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Pelthos Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Pelthos Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Pelthos Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pelthos Therapeutics shares will generate the highest return on investment. By understating and applying Pelthos Therapeutics stock market price indicators, traders can identify Pelthos Therapeutics position entry and exit signals to maximize returns.
Pelthos Therapeutics Return and Market Media
The median price of Pelthos Therapeutics for the period between Thu, Sep 25, 2025 and Wed, Dec 24, 2025 is 28.5 with a coefficient of variation of 14.13. The daily time series for the period is distributed with a sample standard deviation of 4.14, arithmetic mean of 29.31, and mean deviation of 3.6. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Pelthos rolls out campaign aimed at moms who dont mess around - Fierce Pharma | 10/10/2025 |
2 | Will Pelthos Therapeutics Inc. stock beat growth indexes - 2025 Bull vs Bear Growth-Oriented Investment Plans - newser.com | 10/17/2025 |
3 | Acquisition by Ligand Pharmaceuticals Inc of tradable shares of Pelthos Therapeutics at 34.442 subject to Rule 16b-3 | 11/06/2025 |
4 | Pelthos Therapeutics Acquires Xepi Cream, 1 percent and Announces 18 Million Private Convertible Notes Financing | 11/07/2025 |
5 | LGND Target Up On Improved Growth Outlook | 11/10/2025 |
6 | Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results | 11/13/2025 |
7 | Disposition of 2000 shares by Friedberg Ezra M of Pelthos Therapeutics at 28.005 subject to Rule 16b-3 | 11/25/2025 |
8 | Unravel Biosciences Announces Approval by Colombian Health Regulatory Authority to Initiate RVL-001 Clinical Studies for Rett Syndrome and Pitt Hopkins Syndrome | 12/02/2025 |
9 | Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI Topical Gel, 10.3 | 12/04/2025 |
10 | Disposition of 9542 shares by Pauls Matthew of Pelthos Therapeutics subject to Rule 16b-3 | 12/10/2025 |
11 | Pelthos Therapeutics Adds Veteran Finance Executive to Board - TipRanks | 12/23/2025 |
About Pelthos Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pelthos or other stocks. Alpha measures the amount that position in Pelthos Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 | 2025 (projected) | ROE | 0.66 | 1.15 | 2.93 | 3.08 | Income Quality | 0.64 | 0.13 | 0.73 | 0.4 |
Pelthos Therapeutics Investors Sentiment
The influence of Pelthos Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pelthos. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pelthos Therapeutics' public news can be used to forecast risks associated with an investment in Pelthos. The trend in average sentiment can be used to explain how an investor holding Pelthos can time the market purely based on public headlines and social activities around Pelthos Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pelthos Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pelthos Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pelthos Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pelthos Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pelthos Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pelthos Therapeutics' short interest history, or implied volatility extrapolated from Pelthos Therapeutics options trading.
Build Portfolio with Pelthos Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Pelthos Stock Analysis
When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.